Author name: ipessentiacom

Dec 4th, 2020, in Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] the England and […]

On Nov. 30, 2020, the US District Court for the District of Delaware on remand upheld the validity of various

Nov 2020, the European Commission (EC) has fined Teva and its now subsidiary Cephalon 60.5 million euros for agreeing to

The Biologics Price Competition and Innovation Act of 2009 (BPCI Act) established a framework for FDA approval of biosimilars. It

Most of the companies obtain an agreement from employee to assign any patents developed while working on the employer’s business

The introduction of modified versions of original products, is used as a strategy by pharmaceutical companies to switch patients from

Focus of generic pharmaceutical company is mainly on navigating the innovator’s intellectual property and not necessarily on developing a patentable